Incidence of Rhabdomyolysis Among Patients Admitted With Jimsonweed Ingestions

Incidence of Rhabdomyolysis Among Pediatric and Adolescent Patients Admitted for Jimsonweed (Datura Stramonium) Ingestions

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00592657

Enrollment

Registered

2008-01-14

Start date

2008-01-31

Completion date

2008-04-30

Last updated

2008-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemoglobinuria, Myoglobinuria, Rhabdomyolysis

Keywords

retrospective chart review, Jimsonweed ingestion

Brief summary

Retrospective chart review to determine the presence of rhabdomyolysis among patients admitted to CHMCA from 1997-2007 with Jimsonweed ingestions and to define possible risk factors predisposing patients to the developement of Jimsonweed-associated rhabdomyolysis.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

No minimum to 21 Years

Healthy volunteers

Inclusion criteria

* admitted to CHMCA between 1/1/1997 to 12/31/2007 with a qualifying ICD-9 diagnosis code for rhabdomyolysis, myoglobinuria, and hemoglobinuria (728.88, 791.2, 791.3)or other ICD-9 codes identified during the study * between the ages of 0-21 years at diagnosis

Exclusion criteria

* rhabdomyolysis or serum CK concentrations not actually documented * patient admitted to the burn center * patient \> 21 years of age

Design outcomes

Primary

Measure	Time frame
The presence of rhabdomyolysis based on serum CK concentrations in patients admitted with history of Jimsonweed ingestion.	From admission until discharge

Secondary

Measure	Time frame
Renal function, liver function, vital signs, physical exam	From admission until discharge

Countries

United States

Outcome results